Search Results - "Repovic, P."

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Authors: Strijbis E Mostert J D'Haeseleer M et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Apr; Vol. 32 (4), pp. 429-439. Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Authors: Leavitt VM Fox R Mostert J et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Jun; Vol. 31 (7), pp. 866-876. Date of Electronic Publication: 2025 May 08.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study.

Authors: Brochet, Bruno Langdon, Dawn Havrdova, Eva Kubala et al.

Source: Neurology & Therapy. Aug2026, Vol. 15 Issue 4, p1491-1507. 17p.

Investigating the Relationship Between Visual Evoked Potentials, Neurological and Neuropsychological Status in Primary Progressive Multiple Sclerosis.

Authors: Duranović, Jasna Pavelin, Sanda Žnidar, Vanna et al.

Source: Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p5031. 16p.

Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.

Authors: Koch MW Camara-Lemarroy C Strijbis E et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec; Vol. 30 (5_suppl), pp. 41-47. Date of Electronic Publication: 2024 Sep 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

What Is the Evidence on Immunomodulators and Immunosuppressants for Progressive Multiple Sclerosis? - A Cochrane Review Summary with Commentary.

Authors: Moretti, Antimo¹ antimo.moretti@unicampania.it

Source: NeuroRehabilitation. Jun2025, Vol. 56 Issue 4, p577-580. 4p.

Virtual Reality Enables Rapid and Multi-Faceted Vision Screening in a Pilot Study.

Authors: Labkovich, Margarita Warburton, Andrew J. Cheng, Christopher P. et al.

Source: Journal of Clinical & Translational Ophthalmology. Mar2026, Vol. 4 Issue 1, p8. 15p.

Macromolecular Proton Fraction Reveals Divergent White Matter Myelination in Bipolar Disorder and Unipolar Recurrent Depression.

Authors: Gusakova, Sofia Smirnova, Liudmila Borodin, Oleg et al.

Source: Bioengineering (Basel). Jan2026, Vol. 13 Issue 1, p78. 14p.

Transitions in Functional Status and Frailty Among Post-Hospitalized COVID-19 Oldest-Old Adults: An 18-Month Follow-Up Study.

Authors: Saavedra-Palacios, Rafael Álvarez-Bustos, Alejandro Furones-Fernández, Lucía et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p209. 15p.

Demyelination and Cognitive Performance in Long COVID Patients with Insomnia and/or Depression.

Authors: Khodanovich, Marina Kamaeva, Daria Usova, Anna et al.

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 24, p12141. 27p.

Intimate partner violence among women with multiple sclerosis.

Authors: Etemadifar, Masoud Zamani, Omid Bahrami‐Zadegan, Anahita et al.

Source: Psychiatry & Clinical Neurosciences Reports. Dec2025, Vol. 4 Issue 4, p1-6. 6p.

Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.

Authors: Koch MW Moral E Brieva L et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Dec; Vol. 29 (14), pp. 1776-1785. Date of Electronic Publication: 2023 Oct 13.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].

Authors: Newsome, Scott D. Binns, Cherie Kaunzner, Ulrike W. et al.

Source: Neurology & Therapy. Dec2023, Vol. 12 Issue 6, p1909-1935. 27p.

The insidious degeneration of white matter and cognitive decline in Fabry disease.

Authors: Johnson, Jacob W. Baradaran, Hediyeh Morgan, Jubel et al.

Source: PLoS ONE. 11/17/2025, Vol. 20 Issue 11, p1-20. 20p.

Significant Suppression of Multiple Sclerosis in the Mouse EAE Model Using the PrC-210 Aminothiol.

Authors: Fahl, William E. Fahl, Bryan L. Goesch, Sarah R. et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10597. 18p.

Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis.

Authors: Spain RI Hildebrand A Waslo CS et al.

Source: Frontiers in neurology [Front Neurol] 2023 Jun 08; Vol. 14, pp. 1188124. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

The Role of MRI Lesions in Identifying Secondary Progressive Multiple Sclerosis: A Comprehensive Review.

Authors: Anicăi, Robert-Constantin Ciubotaru, Alin Grosu, Cristina et al.

Source: Journal of Clinical Medicine. Jun2025, Vol. 14 Issue 12, p4114. 22p.

From Phenotypes to Spectrum: Rethinking RRMS, SPMS and PPMS in the Era of PIRA—A Framework Integrating PIRA, Smouldering-Associated Worsening, and Neurologic Reserve to Facilitate Earlier Recognition of Progression.

Authors: Vasilev, Georgi V. Ivanova, Sonya Milanov, Ivan

Source: Neurology International. May2026, Vol. 18 Issue 5, p86. 29p.

Cognitive function is associated with risk of conversion to secondary progressive multiple sclerosis: A cross-sectional study.

Authors: Mirmosayyeb, Omid Mohammadi, Ida Rajai Firouzabadi, Shahryar et al.

Source: PLoS ONE. 3/20/2026, Vol. 21 Issue 3, p1-17. 17p.

Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E2 sensitivity in mice with diet-induced MASH.

Authors: Vahrenbrink, Madita Coleman, C. D. Kuipers, S. et al.

Source: Cell Communication & Signaling. 5/16/2025, Vol. 23 Issue 1, p1-17. 17p.